Clinical Scorecard: Topical Use of Gentamicin-Infused Collagen Implants for Preventing Surgical Site Infections in Gastrointestinal Surgery: A Review of Clinical Insights

At a Glance

Key Highlights

• SSI rates are high in GI surgery, particularly in high-risk procedures involving prosthetic implants and pre-operative radiotherapy.
• Gentamicin-collagen implants (GCI) deliver high local antibiotic concentrations with low systemic exposure, reducing SSI risk and antibiotic resistance.
• Clinical studies (n=9) including randomized controlled trials show GCI use reduces wound infection rates, accelerates healing, and shortens hospital stay.

Guideline-Based Recommendations

Diagnosis

• Identify patients at high risk for SSI based on comorbidities, type of GI procedure, and surgical factors.

Management

• Use systemic antibiotic prophylaxis pre- and post-operatively as standard care.
• Consider adjunctive use of resorbable gentamicin-containing collagen implants in high-risk GI surgeries to reduce SSI incidence.
• Apply GCI locally at the surgical site during closure to maximize local antibiotic effect and promote wound healing.

Monitoring & Follow-up

• Monitor for signs of SSI postoperatively including superficial and deep wound infections.
• Assess wound healing progress and complications such as seroma or hematoma formation.
• Observe for adverse reactions related to gentamicin or collagen implants, though immune responses are uncommon.

Risks

• Potential nephrotoxicity and systemic toxicity are minimized due to low serum gentamicin levels with local implant use.
• Risk of antibiotic resistance is reduced by avoiding prolonged systemic antibiotic administration.
• Immune reactions to collagen implants are rare.

Patient & Prescribing Data

483 patients undergoing GI surgery, including 383 treated with Collatamp and 100 with Septocoll

GCI use combined with systemic antibiotics significantly lowers postoperative wound infection rates compared to systemic antibiotics alone, with benefits in wound healing time and hospital stay length.

Clinical Best Practices

• Strict aseptic surgical technique remains essential alongside antibiotic prophylaxis.
• Use GCI as an adjunct to systemic antibiotics in GI surgeries with high SSI risk to enhance prophylaxis.
• Select appropriate GCI product (e.g., Collatamp or Septocoll) based on surgical context and implant characteristics.
• Apply implants carefully to surgical sites to ensure optimal local drug delivery and wound healing support.
• Limit systemic antibiotic duration to reduce resistance, leveraging local antibiotic delivery from GCI.

References

• National and regional surveys on SSI rates in GI surgery
• Systematic review on antibiotic prophylaxis reducing SSI
• Clinical studies on gentamicin-collagen implants in GI surgery
• Carruthers et al. criteria for evidence grading
• Rutten et al. randomized study on GCI in colorectal surgery